Access a curated library of reports, policy submissions, data insights, and other materials informing Canada’s life sciences ecosystem.
October 28, 2025
October 28, 2025
The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.
September 22, 2025
November 04, 2024
November 04, 2024
October 19, 2023
October 19, 2023
Annual cost growth in Canada’s private drug benefit market is driven by increased utilization and chronic disease drugs, with an increase in claimants post‑pandemic.
Read the full report.
September 15, 2023
September 15, 2023
IMC contracted Reformulary Group to analyze the cost of a private plan prescription drug claim in Canada, and separately in Quebec. This report summarizes that analysis.
November 25, 2022
August 01, 2021
August 01, 2021
The 2021 Cost Drivers report highlights the consistent annual cost growth in the Canadian private drug benefits market and outlines factors that contribute to price increases.
August 09, 2018
December 30, 2015
Stay informed with timely, relevant content on key issues shaping our industry.
